SBRT + 💊 in oligomets: 🧍‍♂️2294 pts | 🫁, breast, prostate, colorectal ⚠️Grade 3+ AEs: 1.5% ✅ SBRT Safe with systemic tx! #SBRT #OligoCare #ESTRO25 EORTC ESTRO Ciro Franzese

C. Jillian Tsai, MD, PhD Sushil Shankar Siva Avatar 2 will open soon which is randomized But builds on this and moves away from PFS as the primary endpoint and towards time to treatment failure which reflects actual practice in OPD that oncologists and patients want: SABR and maintain current line

Here is a scientific description of how radiographic scars develop after lung SBRT. #radonc sciencedirect.com/science/articl…

Assessing breast cosmesis used to be a subjective struggle. But AI might just change that. Our team led by AI star, Sangjoon Park & Hwa Kyung Byun , developed an automated, label-free framework that objectively evaluates cosmesis. No labels. ▶️authors.elsevier.com/c/1lFLJ3KEGaU-…

Exciting to bring the tech to USA. I hope the lessons on proton are not repeated. Over 40,000 patients have been treated with carbon ion worldwide. Unclear what cancers this enhances your ability to treat. It is ok to bring new tech and do research with it and not claim it is

❓ESTRO & EORTC proposed a classification to standardize reirradiation. But does it predict outcomes or toxicity? 🫁☢️ We applied the classification in thoracic reirradiation for NSCLC. Here’s what we found. 🧵

I learned this week that SABR-COMET patient #1 recently passed away, more than 12 years after enrollment, with no recurrence since his original SABR. We initially treated him for a left adrenal met. It’s an interesting story… ⬇️⬇️⬇️

#radonc sciencedirect.com/science/articl… Thanks to Dr. Chhabra, and team for spearheading this important discussion. And thanks to the usual suspects that speak up for the health of the field and young doctors. Mudit Chowdhary, MD, Chirag Shah, James Bates

Nice editorial! I agree that physician-led treatment planning is in the best interest of the patient.

Why is World Radiotherapy Day happening on September 7th? It’s because 9/7/1953 is the day the first patient was ever treated with a modern linear accelerator at Hammersmith Hospital in London. #WorldRTDay #WRAD #OneVoiceForRadiotherapy Ref: jpneylon.github.io/ABR/PDFs/Artic…

Treating adrenal gland metastases with SBRT? Check out our latest guide - huge thanks to all collaborators! ASTRO ESTRO the Radiosurgery Society Ben Slotman Simon Lo Dan Ebner Percy Lee MD Shankar Siva Tugce Kutuk, MD, MS practicalradonc.org/article/S1879-…

Rohann Correa’s talk today at the Yonsei RO Grand Round Seminar was incredible.👍 High-level talks like this are truly rare in Korea, where geographical and language barriers remain. It was a big hit—especially inspiring for residents and students. Thanks again, Rohann Correa .🙏

JeeSuk Chang Sympascho Young MD Shankar Siva Thank you for the invitation & warm welcome!! I really enjoyed the excellent discussion with you and your colleagues afterward -- such incisive questions & interesting ideas. Hope to see you again soon!

Reirradiation dose constraints in clinical practice: Results of an international survey. sciencedirect.com/science/articl…

Check out the new updates to #RadOncCalc and RadOnc Tables available now on all platforms (iOS, Android, web) Rad Onc Tables IOS ➡️ is.gd/tnqpTT Android ➡️ is.gd/dzc9xH Rad Onc Calc IOS ➡️ is.gd/txHOue Android ➡️ is.gd/HzIP5x

1/10 📢 Excited to share our new systematic review looking at risks and outcomes of definitive radiotherapy for patients with comorbid ILD and early-stage NSCLC! IJROBP - The Red Journal Melissa Sam Soon Alex Louie MD, PhD Houda Bahig, MD PhD David Palma, MD, PhD authors.elsevier.com/c/1lWCS1Hx52Ns…

Our centre just launched a Rapid Palliative VMAT program, allowing us to quickly create & deliver highly conformal plans to improve symptoms. I've had 2 cases in 2 days. For this one, I did the contours at 10 AM and the plan was ready at 4 PM. 🧵

Since CCTG.HE1 established WLI’s role, we’ve used it more often.💪 Already saw 3 pts with exceptional response — all had DNA repair gene mutations (CHEK2 or ATM).😲 Would be great if CCTG investigators explored tumor sequencing data, if available.🤔Laura Dawson

Ralph Weichselbaum Neil Newman Thank you!! I was hoping folks would chime in with some other high yield things, these are great. To be clear this figure is not my figure, it is from this fantastic publication: pubmed.ncbi.nlm.nih.gov/39864534/

New data from the randomized PEMBRO-RT study demonstrate when an ICI-mediated Abscopal effect is most likely to occur in patients with stage IV NSCLC. Ralph Weichselbaum Sean Pitroda, M.D. Amy L. Cummings, MD PhD doi.org/10.1038/s43018…